Amaqiniso Nge-Neurontin kunye ne-Label-Off-Label Ukusetyenziswa kwi-Bipolar Disorder

Iimpembelelo ezisemacaleni kunye nokuphikisana kwale Milu yokuShatshazwa

I-Neurontin (gabapentin) ngamanye amaxesha icetyiswa ngaphandle-ilebula ukuphatha ingxaki yokuguquka kwe-bipolar .

Makhe sihlolisise izinto ezisiseko kwi-Neurontin, kubandakanywa nemiphumo emibi kwaye ingaba isayensi isekela ukusetyenziswa kwayo njengento yokuzinza.

Ziziphi iimeko zezoNyango i-Neurontin evunyelwe ukuPhatha?

I-Neurontin yipilisi evunyiweyo yi-FDA ukunyanga i-neuralgia yangaphambili kunye ne-postherpetic neuralgia, intlungu ehlalayo emva kokuba umntu ekhwelwe.

Ziziphi iIziphumo eziMbi kakhulu zeNerontin?

Ngokutsho kwe-FDA, i-Neurontin inokunyusa umngcipheko weengcinga okanye ukuziphatha okuzibulala. Izigulane eziphathwe ngayo nayiphi na imishanguzo yokulwa ne-anti-seizure, njenge-Neurontin, kufuneka ilandelwe ukuvela okanye ukugqithisa ukudandatheka, iingcinga zokuzibulala okanye ukuziphatha, kunye / okanye nayiphi na inguqu engaqhelekanga kwimimoya okanye ekuziphatheni.

I-Neurontin inokubangela ukuba isisombululo esinamandla okanye sichaphazele isibindi somntu okanye iiseli zegazi.

Imiqondiso yempendulo engabonakaliyo ingabandakanya ukukhawuleza, ukuphefumula ukuphefumula, umkhuhlane, izigulane ezivuvukayo ezingenakuphucula, okanye ukuvuvukala ubuso, imilomo, umlomo okanye ulwimi.

Iimpawu okanye iimpawu zesibindi okanye iingxaki zeseli zegazi zingabandakanya:

I-Neurontin ingenza umntu azive ehlazo okanye elele. Oku kunokuchaphazela amandla abo okuqhuba.

Ngokutsho kwe-FDA kunye nomvelisi, kubalulekile ukuxoxa nodokotela wakho nokuba ukhuselekile ukuba uqhube ngeyona nto kwi-Neurontin.

Kukwacetyiswa ukuba ugweme utywala kwaye ungathathi amanye amayeza kunye ne-Neurontin de ube uthetha nogqirha wakho, njengoko oku kungonakalisa ukulala kwakho.

Ziziphi iimpembelelo eziqhelekileyo eziqhelekileyo ze-Neurontin?

Ezi ziquka:

Yintoni i-Controversy Surrounding Neurontin's Use in Treating Bipolar Disorder?

Ngelixa uninzi lwamachiza e-anti-seizure, njengeTegretol (carbamazepine), valproate, kunye neLamictal (lamotrigine), avunywe yi-FDA yokunyangwa kwe-bipolar disorder, i-Neurontin (gabapentin) ayikho.

Ngomnyaka we-1993, i-Neurontin yavunywa yi-FDA ukwenzela unyango lwezinto ezixakekileyo ezinqabileyo, ngokudibanisa namanye amachiza okulwa neentambo. Kwaye kwathengiswa ngumvelisi wayo kwi-label-use usetyenziso lokunyangwa kwe-bipolar disorder, nangona kungenanto yolwazi lwesayensi okwaneleyo ukuyibuyisela. Isiphumo siphumelele, njengoko bekukholelwa ukuba i-Neurontin yayithengiswa ngobuqhetseba ngenxa yokusetyenziswa okungavumelekanga.

Ngaba iNzululwazi ixhasa i-Neurontin yokuSebenzisa i-Bipolar Disorder?

Uphononongo luka-2009 kwi- General Hospital Psychiatry, malunga ne-gabapentin njengendlela yokuzinza kwemizwelo, ayifumanekanga ingxelo yeengcamango zokudibanisa imilinganiselo ephakamileyo-kwaye iziphumo zale zifundo zihlolwe zixutywe, zithatha inxaxheba engafanelekanga ekusebenziseni i-gabapentin ekujongeni i-bipolar disorder.

Oko kuthethwa, ngokucwaninga ngo-2007 kwi- Annals General General Psychiatry, i- Neurontin ingasetyenziswa njengonyango olongezelelweyo kunyango lwezilwanyana ezinezifo ezibangelwa yi-bipolar disorder.

Ndingenza ntoni?

Kusoloko kuluvo oluhle lokuba nolwazi ngamachiza akho. Oko kuthethwa, musa ukuthabatha unyango ngaphandle kokuqala ukuthetha nodokotela wakho . Nangona inzululwazi ayinamandla malunga nokuphumelela kwe-gabapentin ekuphatheni i-bipolar disorder, inokukusebenzela yona-umntu ngamnye kufuneka ahlole impendulo yakhe kunye nogqirha wabo.

Imithombo:

FDA. (Ukuhlaziywa ngo-2015). Isikhokelo seMithi: i-Neurontin. Ibuyiswe ngoNovemba 11 ka-2015.

Fountoulakis KN et al. Unyango lweengxaki zokuguquka kwe-bipolar: unyango olunzima kwiimeko ezininzi. Ann Gen Psychiatry. 2007 Oct 9; 6: 27.

Melvin CL et al. Ukusebenza kwezilwanyana zokulwa ne-antiepileptic kunyango lwe-bipolar disorder: iziphumo ezivela kuhlolo oluhlelekile. J Psychiatr Pract. 2008 uMar; iSiza 1: 9-14.

I-Pande AC, i-Crockatt JG, uJanney CA, Werth JL noTsaroucha G. Gabapentin kwi-disorder disorder: i-trialbo elawulwa yi-placebo yonyango oluchaziweyo. Gabapentin Bipolar Disorder Study Group. I-Bipolar Disord . 2000 Septemba; 2 (3 Pt 2): 249-55.

UWilliams JW Jr, uRanney L, uMorgan LC noWhiteener L. Zibujonga njani iindali zesayensi zesigidi se-gabapentin ngenxa yengxaki yokuguquguquka kwengqondo. Gen Hospital Psychiatry 2009 Meyi-Juni; 31 (3): 279-87.